Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 24 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Karavasilis, Vasilios [Clear All Filters]
(2009).
Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcoma..
Sarcoma. 2010, 264360.
(2010).
(2010). Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS)..
BMC Cancer. 12, 342.
(2012). Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer..
J Exp Clin Cancer Res. 31, 77.
(2012). A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas..
J Neurol. 260(6), 1469-80.
(2013). Acquired ichthyosis triggered by an osseous hemangiopericytoma: a case report and review of the literature..
Case Rep Dermatol. 6(1), 10-5.
(2014). Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group..
Anticancer Res. 34(10), 5649-55.
(2014). Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer..
Future Oncol. 10(2), 219-31.
(2014). Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial..
PLoS One. 10(5), e0124612.
(2015).
(2015). Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG)..
World J Urol.
(2015). Wide dissemination of linezolid-resistant Staphylococcus epidermidis in Greece is associated with a linezolid-dependent ST22 clone..
J Antimicrob Chemother. 70(6), 1625-9.
(2015). Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes..
Breast Cancer Res Treat. 158(2), 307-21.
(2016). Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin..
Clin Colorectal Cancer. 15(2), 164-9.
(2016).
(2016). The fate of BRCA1-related germline mutations in triple-negative breast tumors..
Am J Cancer Res. 7(1), 98-114.
(2017). Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers..
Cancer Genomics Proteomics. 14(3), 181-195.
(2017). AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer..
Clin Colorectal Cancer. 17(4), e631-e637.
(2018). Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping..
Med Oncol. 35(7), 101.
(2018). Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer..
Oncotarget. 9(86), 35623-35638.
(2018). Genetic mapping of pancreatic cancer by targeted next-generation sequencing e.
ESMO Open. 4(5), e000525.
(2019). Genotyping and Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment..
Cancer Genomics Proteomics. 16(6), 531-541.
(2019).